These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10539698)

  • 21. Perindopril.
    O'Loughlin DC; Chu VL; Singh D
    Heart Dis; 2000; 2(6):446-55. PubMed ID: 11728296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aldosterone antagonism in addition to angiotensin-converting enzyme inhibitors in heart failure.
    Bauersachs J; Fraccarollo D
    Minerva Cardioangiol; 2003 Apr; 51(2):155-64. PubMed ID: 12783071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
    McMurray JJ; Pfeffer MA; Swedberg K; Dzau VJ
    Circulation; 2004 Nov; 110(20):3281-8. PubMed ID: 15545527
    [No Abstract]   [Full Text] [Related]  

  • 24. The value of diuretics in chronic heart failure demonstrated by an implanted haemodynamic monitor.
    Erdmann E
    Eur Heart J; 2002 Jan; 23(1):7-9. PubMed ID: 11741355
    [No Abstract]   [Full Text] [Related]  

  • 25. Heart failure. A review of current treatment strategies.
    Gross SB
    Adv Nurse Pract; 1999 Jun; 7(6):26-32; quiz 33-4. PubMed ID: 10624177
    [No Abstract]   [Full Text] [Related]  

  • 26. Angiotensin converting enzymes inhibitors in heart failure.
    FitzGerald GR
    Ir Med J; 1993 Mar; 86(2):46-7. PubMed ID: 8473134
    [No Abstract]   [Full Text] [Related]  

  • 27. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current indications for ACE inhibitors and HOPE for the future.
    Burch S; Ou N
    Am J Manag Care; 2002 May; 8(5):478-90; quiz 491-3. PubMed ID: 12019599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diuretics not the first-choice-drug in chronic heart failure].
    Gullestad L; Madsen S
    Tidsskr Nor Laegeforen; 2007 Mar; 127(5):621; author reply 621. PubMed ID: 17332822
    [No Abstract]   [Full Text] [Related]  

  • 30. Old drug gets new life in treating congestive heart failure.
    Mayo Clin Health Lett; 2000 Apr; 18(4):4. PubMed ID: 10815555
    [No Abstract]   [Full Text] [Related]  

  • 31. Heart failure due to left ventricular systolic dysfunction: treatment at discharge from hospital and at one year.
    Houpe D; Peltier M; Cohen-Solal A; Béguin M; Lévy F; Slama M; Chapelain K; Tribouilloy C
    Int J Cardiol; 2005 Sep; 103(3):286-92. PubMed ID: 16098391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Administration of beta blockers for chronic heart failure].
    Walma EP
    Ned Tijdschr Geneeskd; 2000 Nov; 144(48):2325-6. PubMed ID: 11143301
    [No Abstract]   [Full Text] [Related]  

  • 33. Heart failure and angiotensin-converting enzyme inhibitors: towards evidence-based health care.
    Cowie MR; Hardman SM
    Br J Hosp Med; 1995 Mar 1-14; 53(5):186-8. PubMed ID: 7749547
    [No Abstract]   [Full Text] [Related]  

  • 34. Reducing readmissions for congestive heart failure.
    Hoyt RE; Bowling LS
    Am Fam Physician; 2001 Apr; 63(8):1593-8. PubMed ID: 11327436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
    Gronda E; Mangiavacchi M; Andreuzzi B; Municinò A
    Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dangerous hyperkalemia as sequelae of new treatment strategies of heart failure].
    Fuster D; Frey FJ; Ferrari P
    Praxis (Bern 1994); 2000 Dec; 89(49):2073-6. PubMed ID: 11190849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eplerenone: new drug. Recent myocardial infarction with heart failure: a spironolactone me too.
    Prescrire Int; 2006 Apr; 15(82):46-9. PubMed ID: 16604728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concomitant use of a positive inotropic agent to create a bridge to the successful initiation of beta-blocker therapy in patients with heart failure: a proposal for a trial.
    Zampino M; O'Connor CM; Gattis WA; Adams KF; Gheorghiade M
    Am Heart J; 2003 Feb; 145(2 Suppl):S62-6. PubMed ID: 12594456
    [No Abstract]   [Full Text] [Related]  

  • 39. Heart failure: epidemiology, economics and treatment.
    O'Connell JB; Moore CK
    J Miss State Med Assoc; 1996 May; 37(5):569-74. PubMed ID: 8709138
    [No Abstract]   [Full Text] [Related]  

  • 40. Letters to the editors.
    Angerstein RL; Lemberg L; Keller KB
    Am J Crit Care; 2005 Nov; 14(6):468; author reply 468-9. PubMed ID: 16249574
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.